These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17495532)

  • 1. Terminal myeloid differentiation is uncoupled from cell cycle arrest.
    Gibbs JD; Liebermann DA; Hoffman B
    Cell Cycle; 2007 May; 6(10):1205-9. PubMed ID: 17495532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
    Hoffman-Liebermann B; Liebermann DA
    Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
    Gibbs JD; Liebermann DA; Hoffman B
    Oncogene; 2008 Jan; 27(1):98-106. PubMed ID: 17599039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.
    Shafarenko M; Liebermann DA; Hoffman B
    Blood; 2005 Aug; 106(3):871-8. PubMed ID: 15840692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation.
    Shafarenko M; Amanullah A; Gregory B; Liebermann DA; Hoffman B
    Blood; 2004 Jun; 103(11):4259-67. PubMed ID: 14982872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
    Gibbs JD; Liebermann DA; Hoffman B
    Leukemia; 2008 Oct; 22(10):1909-16. PubMed ID: 18650844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
    Selvakumaran M; Liebermann D; Hoffman-Liebermann B
    Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation.
    D'Angelo S; Liebermann D; Hoffman B
    J Cell Physiol; 2008 Jul; 216(1):120-7. PubMed ID: 18247372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication.
    Gandarillas A; Davies D; Blanchard JM
    Oncogene; 2000 Jul; 19(29):3278-89. PubMed ID: 10918584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.
    Freytag SO
    Mol Cell Biol; 1988 Apr; 8(4):1614-24. PubMed ID: 2454393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.
    Acosta JC; Ferrándiz N; Bretones G; Torrano V; Blanco R; Richard C; O'Connell B; Sedivy J; Delgado MD; León J
    Mol Cell Biol; 2008 Dec; 28(24):7286-95. PubMed ID: 18838534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation.
    Barker KA; Newburger PE
    Exp Cell Res; 1990 Jan; 186(1):1-5. PubMed ID: 2404770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.